Bristol-Myers Squibb Company (BMY) analyst actions
Rating and price-target actions on BMY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BMY overview →
No BMY analyst action events in the measured window.
Nothing matched in the current window — the BMY overview has every event we measure for this name.
Get an email when BMY moves on news →Keep exploring
More BMY: earnings → · SEC filings → · BMY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sierra Oncology, Inc. (SRRA) | 649 | -0.03% | 43% |
| Catabasis Pharmaceuticals, Inc. (CATB) | 647 | -0.14% | 45% |
| Five Star Senior Living Inc. - Common Shares (FVE) | 642 | 0.00% | 44% |
| Apollo Endosurgery, Inc. (APEN) | 640 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.